Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2025-12-24 @ 12:23 PM
NCT ID: NCT01439061
Eligibility Criteria: Inclusion Criteria: * Over the age of \>2 years * Under \<18 years of age, or over 18 without fusion of growth plates * Parents' or guardian's written informed consent, given before entering data into the observational study, with the understanding that the subject or parents/guardian may withdraw consent at any time without prejudice to future medical care. If the child is old (over 18 without fusion of growth plates) or able to give written informed consent, a separate assent form will be given Exclusion Criteria: * Subjects taking growth hormone in whom growth plates have fused (i.e. for taking growth hormone for it's metabolic effects) * Contra-indications to SAIZENĀ® as defined in the Summary of Product Characteristics (SmPC) * Use of an investigational drug or participation in another interventional clinical study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 2 Years
Maximum Age: 18 Years
Study: NCT01439061
Study Brief:
Protocol Section: NCT01439061